187 related articles for article (PubMed ID: 17948169)
1. Decursin and decursinol angelate selectively inhibit NADH-fumarate reductase of Ascaris suum.
Shiomi K; Hatano H; Morimoto H; Ui H; Sakamoto K; Kita K; Tomoda H; Lee EW; Heo TR; Kawagishi H; Omura S
Planta Med; 2007 Nov; 73(14):1478-81. PubMed ID: 17948169
[TBL] [Abstract][Full Text] [Related]
2. Decursinol angelate: a cytotoxic and protein kinase C activating agent from the root of Angelica gigas.
Ahn KS; Sim WS; Lee IK; Seu YB; Kim IH
Planta Med; 1997 Aug; 63(4):360-1. PubMed ID: 9270380
[TBL] [Abstract][Full Text] [Related]
3. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
Jung MH; Lee SH; Ahn EM; Lee YM
Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
[TBL] [Abstract][Full Text] [Related]
4. Transport of decursin and decursinol angelate across Caco-2 and MDR-MDCK cell monolayers: in vitro models for intestinal and blood-brain barrier permeability.
Madgula VL; Avula B; Reddy V L N; Khan IA; Khan SI
Planta Med; 2007 Apr; 73(4):330-5. PubMed ID: 17372866
[TBL] [Abstract][Full Text] [Related]
5. Decursinol and decursin protect primary cultured rat cortical cells from glutamate-induced neurotoxicity.
Kang SY; Kim YC
J Pharm Pharmacol; 2007 Jun; 59(6):863-70. PubMed ID: 17637179
[TBL] [Abstract][Full Text] [Related]
6. Paecilaminol, a new NADH-fumarate reductase inhibitor, produced by Paecilomyces sp. FKI-0550.
Ui H; Shiomi K; Suzuki H; Hatano H; Morimoto H; Yamaguchi Y; Masuma R; Sakamoto K; Kita K; Miyoshi H; Tomoda H; Tanaka H; Omura S
J Antibiot (Tokyo); 2006 Sep; 59(9):591-6. PubMed ID: 17136891
[TBL] [Abstract][Full Text] [Related]
7. Biotransformation of plant secondary metabolite decursin by Mycobacterium sp. PYR1001.
Kim KY; Lee S; Cha CJ
J Agric Food Chem; 2010 Mar; 58(5):2931-4. PubMed ID: 20155945
[TBL] [Abstract][Full Text] [Related]
8. Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase.
Son SH; Kim MJ; Chung WY; Son JA; Kim YS; Kim YC; Kang SS; Lee SK; Park KK
Cancer Lett; 2009 Jul; 280(1):86-92. PubMed ID: 19307054
[TBL] [Abstract][Full Text] [Related]
9. Single oral dose pharmacokinetics of decursin, decursinol angelate, and decursinol in rats.
Li L; Zhang J; Xing C; Kim SH; Lü J
Planta Med; 2013 Mar; 79(3-4):275-80. PubMed ID: 23364885
[TBL] [Abstract][Full Text] [Related]
10. Decursin suppresses human androgen-independent PC3 prostate cancer cell proliferation by promoting the degradation of beta-catenin.
Song GY; Lee JH; Cho M; Park BS; Kim DE; Oh S
Mol Pharmacol; 2007 Dec; 72(6):1599-606. PubMed ID: 17855653
[TBL] [Abstract][Full Text] [Related]
11. In vitro inhibitory potential of decursin and decursinol angelate on the catalytic activity of cytochrome P-450 1A1/2, 2D15, and 3A12 isoforms in canine hepatic microsomes.
Abd El-Aty AM; Shah SS; Kim BM; Choi JH; Cho HJ; Hee-Yi ; Chang BJ; Shin HC; Lee KB; Shimoda M; Shim JH
Arch Pharm Res; 2008 Nov; 31(11):1425-35. PubMed ID: 19023539
[TBL] [Abstract][Full Text] [Related]
12. Identification of proteins binding to decursinol by chemical proteomics.
Kang HJ; Yoon TS; Jeong DG; Kim Y; Chung JW; Ha JS; Park SS; Ryu SE; Kim S; Bae KH; Chung SJ
J Microbiol Biotechnol; 2008 Aug; 18(8):1427-30. PubMed ID: 18756104
[TBL] [Abstract][Full Text] [Related]
13. Effects of Angelica gigas Nakai on the production of decursin- and decursinol angelate-enriched eggs.
Fontamillas GAD; Kim SW; Kim HU; Kim SJ; Kim JG; Park TS; Park BC
J Sci Food Agric; 2019 Apr; 99(6):3117-3123. PubMed ID: 30536922
[TBL] [Abstract][Full Text] [Related]
14. Decursin: a cytotoxic agent and protein kinase C activator from the root of Angelica gigas.
Ahn KS; Sim WS; Kim IH
Planta Med; 1996 Feb; 62(1):7-9. PubMed ID: 8720379
[TBL] [Abstract][Full Text] [Related]
15. Mechanism-based inactivation of cytochrome P450 2A6 by decursinol angelate isolated from Angelica Gigas.
Yoo HH; Lee MW; Kim YC; Yun CH; Kim DH
Drug Metab Dispos; 2007 Oct; 35(10):1759-65. PubMed ID: 17620343
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor activities of decursinol angelate and decursin from Angelica gigas.
Lee S; Lee YS; Jung SH; Shin KH; Kim BK; Kang SS
Arch Pharm Res; 2003 Sep; 26(9):727-30. PubMed ID: 14560921
[TBL] [Abstract][Full Text] [Related]
17. Sartorypyrone D: a new NADH-fumarate reductase inhibitor produced by Neosartorya fischeri FO-5897.
Kaifuchi S; Mori M; Nonaka K; Masuma R; Ōmura S; Shiomi K
J Antibiot (Tokyo); 2015 Jun; 68(6):403-5. PubMed ID: 25586023
[No Abstract] [Full Text] [Related]
18. Cloning and characterization of phenylalanine ammonia-lyase and cinnamate 4-hydroxylase and pyranocoumarin biosynthesis in Angelica gigas.
Park JH; Park NI; Xu H; Park SU
J Nat Prod; 2010 Aug; 73(8):1394-7. PubMed ID: 20701298
[TBL] [Abstract][Full Text] [Related]
19. Ukulactone C, a new NADH-fumarate reductase inhibitor produced by Talaromyces sp. FKI-6713.
Kaifuchi S; Mori M; Nonaka K; Masuma R; Ōmura S; Shiomi K
J Gen Appl Microbiol; 2015; 61(2):57-62. PubMed ID: 26018502
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic characterization of decursinol derived from Angelica gigas Nakai in rats.
Song JS; Chae JW; Lee KR; Lee BH; Choi EJ; Ahn SH; Kwon KI; Bae MA
Xenobiotica; 2011 Oct; 41(10):895-902. PubMed ID: 21657833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
